Literature DB >> 15609112

Costing hospital activity: the experience with healthcare resource groups in England.

A Street1, D Dawson.   

Abstract

Development of an English measure of hospital casemix can be traced back to the early 1980s and has resulted in the creation of healthcare resource groups (HRGs). Despite the availability of this casemix classification system, less use has been made of HRG costs than might be expected, primarily because hospitals are not funded on the basis of their casemix adjusted activity. Instead, the main use of casemix information has been in benchmarking exercises, such as the recent example of the government's use of HRG costs to set hospital efficiency targets. This paper outlines the historical context in which HRGs were developed, the data used for classification purposes and the calculation of HRG costs. The responses of hospitals to efficiency targets based on HRG costs are considered, including the options of improving data quality, reducing costs, and ignoring the targets. It is argued that the latter strategy is most evident in England.

Entities:  

Year:  2002        PMID: 15609112     DOI: 10.1007/s10198-001-0086-1

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  3 in total

1.  DRG-based cost minimization models: applications in a hospital environment.

Authors:  Sakesun Suthummanon; Vincent K Omachonu
Journal:  Health Care Manag Sci       Date:  2004-08

2.  A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11.

Authors:  E Pizzo; A A Laverty; K J Phekoo; G AlJuburi; S A Green; D Bell; A Majeed
Journal:  J Public Health (Oxf)       Date:  2014-05-05       Impact factor: 2.341

3.  Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.

Authors:  Ciaran N Kohli-Lynch; James Lewsey; Kathleen A Boyd; Dustin D French; Neil Jordan; Andrew E Moran; Naveed Sattar; David Preiss; Andrew H Briggs
Journal:  Circulation       Date:  2022-03-07       Impact factor: 39.918

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.